Ameritas Investment Partners, Inc. Arrowhead Pharmaceuticals, Inc. Transaction History
Ameritas Investment Partners, Inc.
- $2.98 Billion
- Q4 2024
A detailed history of Ameritas Investment Partners, Inc. transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 37,994 shares of ARWR stock, worth $574,089. This represents 0.02% of its overall portfolio holdings.
Number of Shares
37,994
Previous 37,191
2.16%
Holding current value
$574,089
Previous $720,000
0.83%
% of portfolio
0.02%
Previous 0.02%
Shares
18 transactions
Others Institutions Holding ARWR
# of Institutions
304Shares Held
95.9MCall Options Held
523KPut Options Held
493K-
Black Rock Inc. New York, NY15.7MShares$237 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.2MShares$184 Million0.0% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.1MShares$168 Million3.04% of portfolio
-
State Street Corp Boston, MA6.02MShares$90.9 Million0.0% of portfolio
-
Slate Path Capital LP New York, NY5.23MShares$79.1 Million1.89% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $1.6B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...